Latest News

Biocentury

Biocentury

Priothera raises €30 million to develop onetime Novartis candidate in AML transplantation setting.
Start-up obtains S1PR Modulator from Kyorin.

Press Release

Press Release

Priothera Limited (priothera.com) has successfully closed a Series A financing round of up to €30 million led by Fountain Healthcare Partners with participation from co-lead investor HealthCap and funds managed by Tekla Capital Management, LLC as well as EarlyBird Venture Capital.

Contact Us

Priothera Ltd
88 Harcourt Street, Dublin 2, D02 DK18, Ireland

Priothera Ltd
88 Harcourt Street, Dublin 2,
D02 DK18, Ireland

Priothera SAS France
9 Rue du Temple, Saint Louis, 68300, France